1

拓新破局 共创价值 | 京卫&锐顺亮相CPHI China

发布时间:

2025-06-27 20:19

    第二十三届世界制药原料中国展(CPHI China)于2025年6月24日至26日在上海新国际博览中心盛大启幕。展会汇聚了全球制药行业3500余家优质品牌,覆盖制药原料、制剂、合同定制、生物科技等全产业链,为参展企业把握市场脉搏、拓展全球商机提供了绝佳平台。

京卫制药与锐顺药业联袂亮相 W1D16展位,以专业形象迎接全球客商。展台吸引了众多行业同仁的目光,新老客户纷至沓来,现场洽谈氛围热烈。

京卫&锐顺团队展示了符合国际标准的优质产品与服务,现场营销及技术支持人员专业高效,不仅深入介绍产品在科研创新、质量管控及规模化生产方面的核心优势,重点推介了创新产品、联合研发、定制生产(CXO)及海外授权等多元化合作模式,与全球伙伴探讨构建更深层次、更灵活的战略合作关系。供应链、法规注册、研发等核心部门骨干全程参与,积极收集前沿信息、精准对接业务需求,以“全员营销”理念共同推动公司国际化战略落地。

京卫制药深耕国际市场多年,产品已行销全球80多个国家和地区,建立了广泛的合作网络与良好声誉。本次展会进一步巩固了已有伙伴关系,并成功链接了众多潜在合作方。公司国际事业部将于10月出征德国参与CPHI全球展,持续深化全球布局,向世界更广阔舞台展示京卫实力。

未来,京卫制药将继续秉持“尽责、创新、追求卓越”的核心价值观,以全球患者医疗需求为导向,持续提升产品品质与服务体系,与合作伙伴携手并进,共同为人类健康事业贡献中国制药力量!

 

Open up new business and create value together | Jewim&Risen-sun appear in CPHI China

The 23rd World Pharmaceutical Raw Materials China Exhibition (CPHI China) will grandly kick off from June 24th to 26th, 2025 at the Shanghai New International Expo Center. The exhibition brings together more than 3500 high-quality brands in the global pharmaceutical industry, covering the entire industry chain of pharmaceutical raw materials, formulations, contract customization, biotechnology, etc., providing an excellent platform for exhibitors to grasp the pulse of the market and expand global business opportunities.

Jewim Pharma and Risen-sun Pharma jointly appeared in booth W1D16 to welcome global merchants with a professional image. The exhibition booth attracted the attention of many industry colleagues, with new and old customers flocking in and a lively atmosphere for on-site negotiations.

The Jewim&Risen-sun team demonstrated high-quality products and services in line with international standards. The on-site marketing and technical support personnel were professional and efficient. They not only introduced the core advantages of products in scientific research innovation, quality control and large-scale production, but also introduced diversified cooperation modes such as innovative products, joint research and development, customized production (CXO) and overseas authorization, and discussed with global partners to build deeper and more flexible strategic cooperation relationships. Core departments such as supply chain, regulatory registration, and research and development are fully involved, actively collecting cutting-edge information, accurately matching business needs, and jointly promoting the implementation of the company's internationalization strategy with the concept of "all staff marketing".

Jewim has been deeply involved in the international market for many years, and its products have been sold in more than 80 countries and regions around the world, establishing a wide network of cooperation and a good reputation. This exhibition further consolidated existing partnerships and successfully linked numerous potential partners. The company's international business unit will participate in the CPHI global exhibition in Germany in October, continuously deepening its global layout and showcasing the strength of Jewim to a wider stage around the world.

In the future, Jewim will continue to uphold the core values of "responsibility, innovation, and pursuit of excellence", guided by the global medical needs of patients, continuously improve product quality and service system, work hand in hand with partners, and jointly contribute the strength of Chinese pharmaceuticals to the cause of human health!

内容附件

*.PDF文件点击文件名可在线访问